• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用台湾队列对 SORG 机器学习算法预测脊柱转移瘤患者 90 天和一年生存率进行国际外部验证。

International external validation of the SORG machine learning algorithms for predicting 90-day and one-year survival of patients with spine metastases using a Taiwanese cohort.

机构信息

Department of Orthopedics, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Department of Orthopedics, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Spine J. 2021 Oct;21(10):1670-1678. doi: 10.1016/j.spinee.2021.01.027. Epub 2021 Feb 2.

DOI:10.1016/j.spinee.2021.01.027
PMID:33545371
Abstract

BACKGROUND CONTEXT

Accurately predicting the survival of patients with spinal metastases is important for guiding surgical intervention. The SORG machine-learning (ML) algorithm for the 90-day and one-year mortality of patients with metastatic cancer to the spine has been multiply validated, with a high degree of accuracy in both internal and external validation studies. However, prior external validations were conducted using patient groups located on the east coast of the United States, representing a generally homogeneous population. The aim of this study was to externally validate the SORG algorithms with a Taiwanese population.

STUDY DESIGN/SETTING: Retrospective study at a single tertiary care center in Taiwan PATIENT SAMPLE: Four hundred and twenty-seven patients who underwent surgery for metastatic spine disease from November 1, 2010 to December 31, 2018 OUTCOME MEASURES: 90-day and one-year mortality METHODS: The baseline characteristics of our validation cohort were compared with those of the previously published developmental and external validation cohorts. Discrimination (c-statistic and receiver operating curve), calibration (calibration plot, intercept, and slope), overall performance (Brier score), and decision curve analysis were used to assess the performance of the SORG ML algorithms in this cohort.

RESULTS

Ninety-day and one-year mortality rates were 110 of 427 (26%) and 256 of 427 (60%), respectively. The external validation cohort and the developmental cohort differed in body mass index (BMI), preoperative performance status, American Spinal Injury Association impairment scale, primary tumor histology and in several laboratory measurements. The SORG ML algorithm for 90-day and 1-year mortality demonstrated a high level of discriminative ability (c-statistics of 0.73 [95% confidence interval [CI], 0.67-0.78] and 0.74 [95% CI, 0.69-0.79]), overall performance, and had a positive net benefit throughout the range of threshold probabilities in decision curve analysis. The algorithm for 1-year mortality had a calibration intercept of 0.08, representing a good calibration. However, the 90-day mortality algorithm underestimated mortality for the lowest predicted probabilities, with an overall intercept of 0.81.

CONCLUSIONS

The SORG algorithms for predicting 90-day and 1-year mortality in patients with spinal metastatic disease generally performed well on international external validation in a predominately Taiwanese population. However, 90-day mortality was underestimated in this group. Whether this inconsistency was due to different primary tumor characteristics, body mass index, selection bias or other factors remains unclear, and may be better understood with further validative works that utilize international and/or diverse populations.

摘要

背景

准确预测脊柱转移瘤患者的生存情况对于指导手术干预至关重要。SORG 机器学习(ML)算法可用于预测转移性癌症脊柱转移患者 90 天和 1 年的死亡率,其在内部和外部验证研究中均具有高度准确性。然而,先前的外部验证是在美国东海岸的患者群体中进行的,代表了一个相对同质的人群。本研究旨在使用台湾人群对 SORG 算法进行外部验证。

研究设计/地点:台湾一家三级医疗中心的回顾性研究

患者样本

2010 年 11 月 1 日至 2018 年 12 月 31 日接受脊柱转移瘤手术的 427 例患者

观察指标

90 天和 1 年死亡率

方法

将我们验证队列的基线特征与之前发表的发展和外部验证队列进行比较。使用区分度(c 统计量和接收者操作曲线)、校准(校准图、截距和斜率)、总体性能(Brier 评分)和决策曲线分析来评估 SORG ML 算法在该队列中的性能。

结果

90 天和 1 年的死亡率分别为 427 例中的 110 例(26%)和 256 例(60%)。外部验证队列和发展队列在体重指数(BMI)、术前功能状态、美国脊髓损伤协会损伤量表、原发肿瘤组织学和几项实验室检查方面存在差异。SORG ML 算法对 90 天和 1 年死亡率的预测具有较高的区分能力(90 天的 C 统计量为 0.73[95%置信区间(CI),0.67-0.78]和 1 年的 C 统计量为 0.74[95%CI,0.69-0.79])、总体性能,并且在决策曲线分析中整个阈值概率范围内具有正净收益。1 年死亡率算法的校准截距为 0.08,表明校准良好。然而,90 天死亡率算法低估了最低预测概率下的死亡率,总体截距为 0.81。

结论

SORG 算法可用于预测脊柱转移瘤患者的 90 天和 1 年死亡率,在以台湾人为主的国际外部验证中总体表现良好。然而,在这组人群中,90 天的死亡率被低估了。这种不一致是否是由于原发肿瘤特征、体重指数、选择偏倚或其他因素不同所致尚不清楚,进一步利用国际和/或多样化人群进行验证性研究可能会更好地理解这一点。

相似文献

1
International external validation of the SORG machine learning algorithms for predicting 90-day and one-year survival of patients with spine metastases using a Taiwanese cohort.使用台湾队列对 SORG 机器学习算法预测脊柱转移瘤患者 90 天和一年生存率进行国际外部验证。
Spine J. 2021 Oct;21(10):1670-1678. doi: 10.1016/j.spinee.2021.01.027. Epub 2021 Feb 2.
2
Does the SORG algorithm generalize to a contemporary cohort of patients with spinal metastases on external validation?SORG 算法在外验证队列中是否能推广应用于当代脊柱转移瘤患者?
Spine J. 2020 Oct;20(10):1646-1652. doi: 10.1016/j.spinee.2020.05.003. Epub 2020 May 16.
3
International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.国际验证 SORG 机器学习算法在预测接受手术治疗的肢体转移患者生存情况的应用。
Clin Orthop Relat Res. 2022 Feb 1;480(2):367-378. doi: 10.1097/CORR.0000000000001969.
4
External validation of the SORG machine learning algorithms for predicting 90-day and 1-year survival of patients with lung cancer-derived spine metastases: a recent bi-center cohort from China.用于预测肺癌脊柱转移患者90天和1年生存率的SORG机器学习算法的外部验证:来自中国的一项近期双中心队列研究
Spine J. 2023 May;23(5):731-738. doi: 10.1016/j.spinee.2023.01.008. Epub 2023 Jan 25.
5
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?骨肿瘤研究组算法对软骨肉瘤患者 5 年生存率的预测在国际验证中的表现如何?
Clin Orthop Relat Res. 2020 Oct;478(10):2300-2308. doi: 10.1097/CORR.0000000000001305.
6
External validation of the SORG 90-day and 1-year machine learning algorithms for survival in spinal metastatic disease.SORG 90 天和 1 年机器学习算法在脊柱转移瘤患者生存中的外部验证。
Spine J. 2020 Jan;20(1):14-21. doi: 10.1016/j.spinee.2019.09.003. Epub 2019 Sep 7.
7
Does the SORG Machine-learning Algorithm for Extremity Metastases Generalize to a Contemporary Cohort of Patients? Temporal Validation From 2016 to 2020.SORG 机器学习算法对肢体转移瘤的泛化能力如何?2016 年至 2020 年的时间验证。
Clin Orthop Relat Res. 2023 Dec 1;481(12):2419-2430. doi: 10.1097/CORR.0000000000002698. Epub 2023 May 25.
8
Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.SORG 算法能否预测软骨肉瘤患者的 5 年生存率?一项外部验证。
Clin Orthop Relat Res. 2019 Oct;477(10):2296-2303. doi: 10.1097/CORR.0000000000000748.
9
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
10
Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.缺失数据的存在是否会影响 SORG 机器学习算法在脊柱转移瘤患者中的性能?开发一种互联网应用算法。
Clin Orthop Relat Res. 2024 Jan 1;482(1):143-157. doi: 10.1097/CORR.0000000000002706. Epub 2023 Jun 12.

引用本文的文献

1
Artificial Intelligence Models for Predicting Outcomes in Spinal Metastasis: A Systematic Review and Meta-Analysis.预测脊柱转移瘤预后的人工智能模型:一项系统评价和荟萃分析
J Clin Med. 2025 Aug 20;14(16):5885. doi: 10.3390/jcm14165885.
2
Artificial Intelligence in bone Metastases: A systematic review in guideline adherence of 92 studies.人工智能在骨转移中的应用:对92项研究指南依从性的系统评价
J Bone Oncol. 2025 Apr 24;52:100682. doi: 10.1016/j.jbo.2025.100682. eCollection 2025 Jun.
3
Outcome prediction, quality of life, and life expectancy in metastatic spine tumors: WFNS spine committee recommendation.
转移性脊柱肿瘤的预后预测、生活质量及预期寿命:世界神经外科联合会脊柱委员会建议
Neurosurg Rev. 2025 Feb 3;48(1):160. doi: 10.1007/s10143-025-03298-3.
4
Temporal validation of the SORG 90-Day and 1-Year machine learning algorithms for survival of patients with spinal metastatic disease.SORG 90天和1年机器学习算法对脊柱转移性疾病患者生存情况的时间验证
Eur Spine J. 2024 Dec 5. doi: 10.1007/s00586-024-08588-w.
5
Revolutionizing spinal interventions: a systematic review of artificial intelligence technology applications in contemporary surgery.颠覆脊柱介入治疗:人工智能技术在当代手术中应用的系统评价。
BMC Surg. 2024 Nov 5;24(1):345. doi: 10.1186/s12893-024-02646-2.
6
Current Applications and Future Implications of Artificial Intelligence in Spine Surgery and Research: A Narrative Review and Commentary.人工智能在脊柱外科手术与研究中的当前应用及未来影响:一项叙述性综述与评论
Global Spine J. 2025 Mar;15(2):1445-1454. doi: 10.1177/21925682241290752. Epub 2024 Oct 2.
7
Clinical, oncological, and prognostic differences of patients with subsequent skeletal-related events in bone metastases.骨转移患者发生后续骨相关事件的临床、肿瘤学及预后差异。
Bone Joint Res. 2024 Sep 16;13(9):497-506. doi: 10.1302/2046-3758.139.BJR-2023-0372.R1.
8
Impact of perioperative hemoglobin-related parameters on clinical outcomes in patients with spinal metastases: identifying key markers for blood management.围手术期血红蛋白相关参数对脊柱转移瘤患者临床结局的影响:确定血液管理的关键指标
BMC Musculoskelet Disord. 2024 Aug 8;25(1):632. doi: 10.1186/s12891-024-07748-9.
9
Development and internal validation of machine-learning models for predicting survival in patients who underwent surgery for spinal metastases.用于预测接受脊柱转移瘤手术患者生存率的机器学习模型的开发与内部验证
Asian Spine J. 2024 Jun;18(3):325-335. doi: 10.31616/asj.2023.0314. Epub 2024 May 20.
10
Predictive Modeling for Spinal Metastatic Disease.脊柱转移性疾病的预测模型
Diagnostics (Basel). 2024 May 5;14(9):962. doi: 10.3390/diagnostics14090962.